[Iron overload and liver diseases (except for hemochromatosis and dysmetabolic hepatosiderosis].

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Bulletin de l'Académie Nationale de Médecine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 10989543
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions.

  1999cited by this paper
• Extremely rare association of HFE mutations with porphyria cutanea tarda in japanese patients

  1999cited by this paper
• [Iron overload and HFE gene].

  1999cited by this paper
• C282Y and H63D mutations in the HFE gene are not associated with porphyria cutanea tarda in bulgaria

  1999cited by this paper
• Hemochromatosis Cys282Tyr mutation and liver iron overload in patients with chronic active hepatitis C

  1998cited by this paper
• Nonalcoholic steatohepatitis.

  1997cited by this paper
• Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment.

  1997cited by this paper
• A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: practical implications for the diagnosis of hemochromatosis.

  1997cited by this paper
• Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda.

  1997cited by this paper
• A new syndrome of liver iron overload with normal transferrin saturation.

  1997cited by this paper
• Iron and chronic viral hepatitis

  1997cited by this paper
• Hemosiderosis in cirrhosis: a study of 447 native livers.

  1997cited by this paper
• A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis

  1996cited by this paper
• Iron in Liver Diseases Other than Hemochromatosis

  1996cited by this paper
• Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver

  1995cited by this paper

• Toxicity Study of a Novel Oral Iron Chelator: 1-(N-Acetyl-6-Aminohexyl)-3 Hydroxy-2-Methylpyridin-4-One (CM1) in Transgenic b-Thalassemia Mice

  2013cites this paper
• Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis

  2005cites this paper